LSO’sAnnual Policy Forum, now entering its 10th year, brings together key stakeholders to strategize how we can accelerate our life sciences sector. The 2019 Policy Forum, features speakers from a broad spectrum of industry and government as well as robust opportunities for audience engagement.
All tickets are being held for pickup at the Registration Desk. Please arrive on time. The Registration Desk opens at 8:00 A.M. and the session will begin promptly at 8:30 A.M.
LOCATION: Borden Ladner Gervais LLP
Bay Adelaide Centre, E. Tower
22 Adelaide St W., 34th floor
Toronto, ON M5H 4E3
|8:00 am||Registration & Breakfast|
|8:30 am - 4:00 pm||Presentations|
|4:00 pm - 5:30 pm||Reception|
Sachin Aggarwal, CEO, Think Research
• Cindy Bell, Executive Vice President, Corporate Development, Genome Canada
• Abigail Carter-Langford, Vice President, Governance, Risk & Compliance and Chief Privacy Officer, Canada Health Infoway
• Bill Dempster, President, 3Sixty Public Affairs
• Shelley Epstein, Vice President – Corporate and Public Affairs, Imagia
• Deborah Gordon-El-Bihbety, President and CEO, Research Canada
• Shiran Isaacksz, Senior Director, UHN Connected Care
• Bartha Maria Knoppers, Director, Centre of Genomics and Policy, Faculty of MedicineDepartment of Human Genetics, McGill University
• Scott MacNair, General Manager, Stryker
• Michelle McLean, Senior Vice President, Health and Wellness, Hill+Knowlton StrategiesCanada
• Seema Nagpal, Vice President, Science, and Policy, Diabetes Canada
• Alison Paprica, VP, Health Strategy and Partnership, Vector Institute
• Dan Sinai, Senior Innovation Leader - IBM Canada Research and Development Centre
• Ryan Wiley, President, Shift Health
• Trevin Stratton, Chief Economist, Canadian Chamber of Commerce
• Mette Harbo, Head of Digitization, City of Copenhagen, Health and Care Administration
• Malcolm Campbell, Professor & Vice-President Research, University of Guelph
Life Sciences Policy Post Federal Election Life sciences policies played a major role leading up to the federal election
National pharmacare, PMPRB reform, and the HBEST Strategy all played important roles in party platforms. With a new government in place, what is emerging in terms of policy directions and priorities for our life sciences sector? What role will digital transformations play in health and economic policies? How does this align (or not) with Ontario initiatives and policy priorities?
Big Data – Unlocking the Opportunity
Ontario is sitting on a treasure trove of health data but unlocking its potential remains an elusive challenge. Privacy, informed consent, for-profit-use and access are rising concerns. In this session, panel members will identify key policy priorities for Ontario to unlock this potential and mitigate risk.
AI, Machine Learning and Automation in the BioEconomy
Technology is evolving at a rapid pace and businesses need to adapt in order to stay relevant. In this session, panel members will discuss the potential impacts of these areas on life sciences? How do we facilitate advancement and adoption of these technologies through public policies? How should we be preparing our workforce to be at the forefront of this technological revolution?
LSO 30th Anniversary and Holiday Reception